The metabolic disorder therapeutics market has been undergoing a substantial transformation over the past decade. Valued at USD 77.59 billion in 2024, the market is poised to reach USD 140.29 billion by 2032, growing at a healthy CAGR of 8.32% from 2025 to 2032. This growth is powered by the increasing prevalence of metabolic diseases such as diabetes, obesity, and lysosomal storage disorders,...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek